Stochastic variation in network epidemic models: Implications for the design of community level HIV prevention trials

Statistics in Medicine

Volumn 33, Issue 22, 2014, Pages 3894-3904

  Boren, David ^a   Sullivan, Patrick S ^b   Beyrer, Chris ^c   Baral, Stefan D ^c   Bekker, Linda Gail ^d   Brookmeyer, Ron ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMORY UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Community randomized trials; Epidemics; HIV; Networks; Sample size

Indexed keywords

BISEXUALITY; HIV INFECTIONS; HUMAN; MALE; MALE HOMOSEXUALITY; MARKOV CHAIN; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; SOUTH AFRICA; STATISTICAL MODEL;

BISEXUALITY; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MODELS, STATISTICAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SAMPLE SIZE; SOUTH AFRICA; STOCHASTIC PROCESSES;

EID: 84906943618     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.6193     Document Type: Article

References (32)

1. Bekker L, Beyrer C, Quinn T. Behavioral and biomedical combination strategies for HIV prevention. Cold Spring Harbor Perspectives in Medicine 2012; 2(8):1-23.
2. Sullivan P, Carballo-Diéguez A, Coates T, Goodreau S, McGowan I, Sanders E, Smith A, Goswami P, Sanchez J. Successes and challenges of HIV prevention in men who have sex with men. The Lancet 2012; 380(9839):388-399.
3. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JHS, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR. Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine 2011; 365(6):493-505.
4. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapia M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernandez T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker L, Mayer KH, Kallas EG, Amico R, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell J, Zheng J, Lee J, Rooney JF, Jafe HS, Martinez AI, Burns DN, Glidden DV. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine 2010; 363(27):2587-2599.
5. Lagakos SW, Gable AR. Challenges to HIV prevention-seeking effective measures in the absence of a vaccine. New England Journal of Medicine 2008; 358(15):1543-1545.
6. El-Sadr W, Serwadda D, Sisa N, Cohen M. HIV prevention: more challenges ahead. JAIDS Journal of Acquired Immune Deficiency Syndromes 2013; 63: S115-116.
7. Institute of Medicine. Methodological Challenges in Biomedical HIV Prevention Trials. The National Academies Press: Washington DC, 2008.
8. Hayes R, Moulton L. Cluster Randomized Trials. Chapman and Hall/CRC press: London, 2009.
9. Donner A, Klar N. Design and Analysis of Cluster Randomizaton Trials in Health Research. Arnold Publishers: London, 2000.
10. Gail MH, Byar DP, Pechacek TF, Corle DK. Aspects of statistical design for the Community Intervention Trial for Smoking Cessation (COMMIT). Controlled Clinical Trials 1992; 13(1):6-21.
11. Donner A, Birkett N, Buck C. Randomization by cluster: sample size requirements and analysis. American Journal of Epidemiology 1981; 114(6):906-914.
12. Koepsell TD, Martin DC, Diehr PH, Psaty BM, Wagner EH Perrin EB, Cheadle A. Data analysis and sample size issues in evaluations of community-based health promotion and disease prevention programs: a mixed-model analysis of variance approach. Journal of Clinical Epidemiology 1991; 44(7):701-713.
13. Hsieh FY. Sample size formulae for intervention studies with the cluster as unit of randomization. Statistics in Medicine 1988; 7(11):1195-1201.
14. Hayes RJ, Bennett S. Simple sample size calculation for cluster-randomized trials. International Journal of Epidemiology 1999; 28(2):319-326.
15. Wang R, Goyal R, Lei Q, Essex M, DeGruttola V. Sample size considerations in the design of cluster randomized trials of combination HIV prevention. Working Paper 161, Harvard University Biostatistics Working Paper Series, 2013. (Available from: http://biostats.bepress.com/harvardbiostat/paper161).
16. Cochran W. Sampling Techniques. John Wiley & Sons, 1997.
17. Bonabeau E. Agent-based modeling: methods and techniques for simulating human systems. Proceedings of the National Academy of Sciences of the United States of America 2002; 99(Suppl 3):7280-7287.
18. Epstein J. Agent-based computational models and generative social science. Generative Social Science: Studies in Agent-Based Computational Modeling 1999: 4-46.
19. Auchincloss A, Diez Roux A. A new tool for epidemiology: the usefulness of dynamic-agent models in understanding place effects on health. American Journal of Epidemiology 2008; 168(1):1-8.
20. Halloran M, Longini I, Nizam A, Yang Y. Containing bioterrorist smallpox. Science 2002; 298(5597):1428-1432.
21. Longini IM, Halloran ME, Nizam A, Yang Y, Xu S, Burke DS, Cummings AT, Epstein JM. Containing a large bioterrorist smallpox attack: a computer simulation approach. International Journal of Infectious Diseases 2007; 11(2):98-108.
22. Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, Matrajt L, Potter G, Kenah E, Longini IM. The transmissibility and control of pandemic influenza A (H1N1) virus. Science 2009; 326(5953):729-733.
23. Goyal R, Wang R, De Gruttola V. Network epidemic models: assumptions and interpretations. Clinical Infectious Diseases 2012; 55(2):276-8.
24. Beyrer C, Baral SD, van Griensven F, Goodreau SM, Chariyalertsak S, Wirtz AL, Brookmeyer R. Global epidemiology of HIV infection in men who have sex with men. The Lancet 2012; 380(9839):367-377.
25. Baral S, Burrell E, Scheibe A, Brown B, Beyrer C, Bekker LG. HIV risk and associations of HIV infection among men who have sex with men in peri-urban Cape Town, South Africa. BMC Public Health 2011; 11(1):766.
26. Goodreau SM, Goicochea LP, Sanchez J. Sexual role and transmission of HIV Type 1 among men who have sex with men, in Peru. Journal of Infectious Diseases 2005; 191(Supplement 1):S147-S158.
27. Holland PW, Leinhardt S. An exponential family of probability distributions for directed graphs. Journal of the American Statistical Association 1981; 76(373):33-50.
28. Anderson PL, Glidden D, Liu A, Buchbinder S, Lama J, Guanira JV, McMahan V. et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Science Translational Medicine 2012; 151: 151ra125.
29. Koblin BA. Effects of a behavioral intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomized controlled study. The Lancet 2004; 3 364(9428):41-50.
30. Marx BD. Iteratively reweighted partial least squares estimation for generalized linear regression. Technometrics 1996; 38(4):374-381.
31. Magnani R, Sabin K, Saidel T, Heckathorn D. Review of sampling hard to reach and hidden populations for HIV surveillance. AIDS 2005; 19(supp 2):S67-S72.
32. Salganik MJ. Variance estimation, design effects and sample size calculations for respondent driven sampling. Journal of Urban Health 2006; 83(7):i98-i112.